Skip to main content

Designing Studies for Assessing Efficacy in Mixture Populations

  • Conference paper
  • First Online:

Part of the book series: Springer Proceedings in Mathematics & Statistics ((PROMS,volume 55))

Abstract

In personalized medicine, the patient population is thought of as a mixture of two or more subgroups that might derive differential efficacy from a drug. A decision to make is which subgroup or union of the subgroups should the drug be developed for. Interestingly, some common measures of efficacy are such that its value for a mixture population may not be representable as a function of efficacy for the subgroups and their prevalence. This chapter describes design of study that would lead to probabilistic models so that relative risk (or odds ratio) for a mixture population can be represented as a function of relative risk (or odds ratio) for the subgroups and their prevalence.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Good, I. J. and Mittal, Y. (1987). The amalgamation and geometry of two-by-two contingency tables. Annals of Statistics, 15:694–711.

    Article  MathSciNet  MATH  Google Scholar 

  2. Hsu, J. C. (1996). Multiple Comparisons: Theory and Methods. Chapman & Hall, London.

    Book  MATH  Google Scholar 

  3. Mallal, S., Nolan, D., Witt, C., Masel, G., Martin, A. M., Moore, C., Sayer, D., Castley, A., Mamotte, C., Maxwell, D., James, I., and Christiansen, F. T. (2002). Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. The Lancet, 359:727–732.

    Article  Google Scholar 

  4. Paré, G., Mehta, S. R., Yusuf, S., Anand, S. S., Connolly, S. J., Hirsh, J., Simonsen, K., Bhatt, D. L., Fox, K. A., and Eikelboom, J. W. (2010). Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. New England Journal of Medicine, 363:1704–1714.

    Article  Google Scholar 

Download references

Acknowledgments

This research is supported in part by NSF grant DMS-1007794.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Szu-Yu Tang .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this paper

Cite this paper

Tang, SY., Kaizar, E., Hsu, J.C. (2013). Designing Studies for Assessing Efficacy in Mixture Populations. In: Hu, M., Liu, Y., Lin, J. (eds) Topics in Applied Statistics. Springer Proceedings in Mathematics & Statistics, vol 55. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7846-1_6

Download citation

Publish with us

Policies and ethics